Letters to the Editor
Clinical pharmacology in the NHS From Dr T B Binns Department of Pharmacology and Therapeutics, London Hospital Medical College, London EI 2AD Sir, I was glad to see Professor Rawlins' recent editorial (August Journal, p 556) . It is now more than twenty-five years since Gold (1952) coined the term 'clinical pharmacology', but apart from small units in teaching hospitals, the discipline has never really caught on. Among the reasons are that it cuts across other specialities, that people wrongly associate it with esoteric and expensive metabolism studies, or that they simply do not know what the term means. There are precedents for this. It is said that the US National Institute of Microbiology had great difficulty in getting money from Congress until it became apparent that Congressmen did not know what microbiology was. When the name was changed to the National Institute of Allergy and Infectious Diseases the money came rolling in. It is therefore up to clinical pharmacologists to make clear what they have to ofTer and, with the encouragement of the Medico-Pharmaceutical Forum (1975) , the Clinical Section of the British Pharmacological Society issued a statement on the role of the clinical pharmacologist in district general hospitals (Clinical Pharmacology Section 1978) . In addition to numerous highly practical service functions, this lays emphasis, as does Professor Rawlins, .on the educational role of clinical pharmacologists not only in the hospital but in the surrounding district, since general practitioners are responsible for about 85 0 0 of all prescribing. It ties in nicely with the recent article (February Journal, p 88) in which Dr J W Paulley says that the educational role of the district hospital has been steadily increasing and will continue to grow.
There is a lot of emotive and ill-informed talk about drugs, with too much emphasis on reducing their cost and not enough on increasing their benefit (e.g. The Times, 12 July 1978). There is a curious and unfortunate tendency to equate good prescribing with cheap prescribing. As the late Henry Miller pointed out some years ago, there is no known correlation between the two (Miller & Smith 1960) .
The proportion of total health costs spent on drugs has in fact fallen slightly over the past few years. In England and Wales drugs cost almost £600 million in 1977 £600 million in (Lancet 1978 . Despite the Pharmaceutical Price Regulation Scheme, there may still be some anomalous prices and of course no one would condone unnecessary waste, but the overall costs of drugs could not be much reduced without further imperilling the viability of the research-based industry on which future therapeutic progress largely depends. Although the industry is highly efficient, its profitability was reported by Mr Ennals now to be no higher than that of British industry in general (Lancet 1976) . Even the Sainsbury Committee (1967), which could not be accused of pro-industry bias, recognized that its profitability needed to be above average, because of the exceptionally high cost and risk of research. The factors that led to this view have deteriorated greatly since then. On the other hand, there is plenty of scope for improving the general quality of prescribing. If doctors really used available drugs efficiently, the public benefit would increase substantially and some reduction in cost would almost certainly follow. Products of doubtful value would disappear from the market and genuine innovation would beencouraged.
It is now very difficult for anyone to use drugs consistently well, and in no branch of medicine is continuing education more important (Medico-Pharmaceutical Forum 1975) . A clinical pharmacologist at a district hospital would be the ideal focus for it. Such appointments could hardly fail to pay for themselves in cost-benefit terms. For a start, I would strongly support the proposal of Hunter (1975) that a small number of posts should be created and judged by results. It is simply not true, as has been suggested, that suitable people are not available. One almost unique appointment a couple of years ago attracted a very fine group of applicants. If career prospects improve, more will enter the specialty and vice versa. In 1975 an editorial statement in Health Trends said, presumably with official blessing: 'The NHS will have to participate in the development of this specialty'. Some constructive initiative is already overdue. , p 702) , I had no intention (see June, P 399) of denigrating the community health councils; when they set up working parties of experts to study a particular problem in the way she describes, the result should be excellent. But whether the CHCs will be effective in maintaining nursing standards, especially in long-stay hospitals, and in preventing further disasters like that at the Ely Hospital, remains to be seen. Of course, I hope they will. But as I suggested in the next paragraph (p 404), part of the answer to this problem must surely lie in making the professional lives of the long-term nurses interesting and rewarding, and this is the responsibility of nursing administrators. not of community health councils. Journal, p 353) gives the impression that insertion of grommets is standard surgical practice. Most otologists agree that ears with thin serous or seromucinous fluid with minimal hearing losses (up to 20-25 dB) do not require use of ventilating tubes. Unless the criteria for use of grommets are clearly defined, controlled trials for mixed groups of cases only create misunderstanding for non-specialist readers.
Whilst I entirely agree with Mr Bull's remarks (July, p 543), very few otologists have the facility to see or admit children within a few weeks of referral. The classic British waiting list is, in itself, a type of conservative management. In my experience, the question of parental pressure does not arise in NHS practice. Yours sincerely N SHAH 31 July 1978
Correction
The first sentence of Mr James P S Thomson's letter on lateral subcutaneous sphincterotomy (August Journal, p 627) should read: As surgeons we should not over-treat our patients.
